Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lee Marshall Nadler, M.D.

Co-Author

This page shows the publications co-authored by Lee Nadler and Stuart Schlossman.
Connection Strength

1.283
  1. Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma. Lancet. 1984 Aug 25; 2(8400):427-31.
    View in: PubMed
    Score: 0.076
  2. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol. 1983 Jul; 131(1):244-50.
    View in: PubMed
    Score: 0.070
  3. Induction of human B cell antigens in non-T cell acute lymphoblastic leukemia. J Clin Invest. 1982 Aug; 70(2):433-42.
    View in: PubMed
    Score: 0.066
  4. Characterization of a human B cell-specific antigen (B2) distinct from B1. J Immunol. 1981 May; 126(5):1941-7.
    View in: PubMed
    Score: 0.061
  5. Monoclonal antibodies defining serologically distinct HLA-D/DR related Ia-like antigens in man. Hum Immunol. 1981 Feb; 2(1):77-90.
    View in: PubMed
    Score: 0.060
  6. Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies. Prog Hematol. 1981; 12:187-225.
    View in: PubMed
    Score: 0.059
  7. Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen. Cancer Res. 1980 Sep; 40(9):3147-54.
    View in: PubMed
    Score: 0.058
  8. A monoclonal antibody defining a lymphoma-associated antigen in man. J Immunol. 1980 Aug; 125(2):570-7.
    View in: PubMed
    Score: 0.058
  9. Heterogeneity of T-cell lymphoblastic malignancies. Blood. 1980 May; 55(5):806-10.
    View in: PubMed
    Score: 0.057
  10. The T lymphoblastic malignancies. Cancer Chemother Pharmacol. 1980; 4(1):11-5.
    View in: PubMed
    Score: 0.055
  11. Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrow. Blood. 1987 Feb; 69(2):597-604.
    View in: PubMed
    Score: 0.023
  12. Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes. Eur J Immunol. 1986 Aug; 16(8):881-7.
    View in: PubMed
    Score: 0.022
  13. Dual fluorochrome analysis of human B lymphocytes: phenotypic examination of resting, anti-immunoglobulin stimulated, and in vivo activated B cells. J Immunol. 1986 May 15; 136(10):3612-8.
    View in: PubMed
    Score: 0.021
  14. Studies of the in vitro activation and differentiation of human B lymphocytes. II. Optimization of activation by anti-immunoglobulin antibody bound to beads: analysis of the role of autocrine effects on B-cell proliferation and of T-cell help in B-cell differentiation. Cell Immunol. 1986 Apr 15; 99(1):228-40.
    View in: PubMed
    Score: 0.021
  15. Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells. J Immunol. 1985 Sep; 135(3):1746-51.
    View in: PubMed
    Score: 0.020
  16. The B cell surface molecule B1 is functionally linked with B cell activation and differentiation. J Immunol. 1985 Aug; 135(2):973-9.
    View in: PubMed
    Score: 0.020
  17. Structural and functional characterization of IL 2 receptors on activated human B cells. J Immunol. 1985 Apr; 134(4):2387-92.
    View in: PubMed
    Score: 0.020
  18. B5, a new B cell-restricted activation antigen. J Immunol. 1985 Apr; 134(4):2228-35.
    View in: PubMed
    Score: 0.020
  19. Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody. J Immunol. 1985 Mar; 134(3):1516-23.
    View in: PubMed
    Score: 0.020
  20. Hairy cell leukemia: a tumor of pre-plasma cells. Blood. 1985 Mar; 65(3):620-9.
    View in: PubMed
    Score: 0.020
  21. Immunologic heterogeneity of diffuse large cell lymphoma. Blood. 1985 Mar; 65(3):630-7.
    View in: PubMed
    Score: 0.020
  22. Isolation and functional analysis of human B cell populations. I. Characterization of the B1+B2+ and B1+B2- subsets. J Immunol. 1985 Feb; 134(2):820-7.
    View in: PubMed
    Score: 0.020
  23. A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells. J Immunol. 1984 Jun; 132(6):3172-9.
    View in: PubMed
    Score: 0.019
  24. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood. 1984 Jun; 63(6):1424-33.
    View in: PubMed
    Score: 0.019
  25. Surface antigen changes during B-lymphocyte activation in primates. Cell Immunol. 1984 Mar; 84(1):163-70.
    View in: PubMed
    Score: 0.018
  26. Isolation and characterization of human B lymphocyte enriched populations. I. Purification of B cells by immune rosette depletion. J Immunol Methods. 1983 Jul 29; 61(3):283-92.
    View in: PubMed
    Score: 0.018
  27. Ontogeny of human hematopoietic cells: analysis utilizing monoclonal antibodies. J Immunol. 1983 Jul; 131(1):232-7.
    View in: PubMed
    Score: 0.018
  28. Antigens on human plasma cells identified by monoclonal antibodies. J Immunol. 1983 Mar; 130(3):1132-8.
    View in: PubMed
    Score: 0.017
  29. Differentiation patterns in the blastic phase of chronic myeloid leukemia. Blood. 1983 Jan; 61(1):85-91.
    View in: PubMed
    Score: 0.017
  30. Serologic identification of the human secondary B cell antigens. Correlations between function, genetics, and structure. J Exp Med. 1982 Sep 01; 156(3):731-43.
    View in: PubMed
    Score: 0.017
  31. Comparison in T- and B-cell markers in patients with Sjögren's syndrome and systemic lupus erythematosus. Clin Immunol Immunopathol. 1982 Feb; 22(2):270-8.
    View in: PubMed
    Score: 0.016
  32. Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J Clin Invest. 1981 Oct; 68(4):932-41.
    View in: PubMed
    Score: 0.016
  33. Stages of B cell differentiation in human lymphoid tissue. J Exp Med. 1981 Sep 01; 154(3):737-49.
    View in: PubMed
    Score: 0.016
  34. Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage. Blood. 1981 Sep; 58(3):648-52.
    View in: PubMed
    Score: 0.016
  35. Lymphoid subpopulations of peripheral blood and spleen in untreated Hodgkin's disease. Cancer. 1981 Sep 01; 48(5):1170-6.
    View in: PubMed
    Score: 0.016
  36. Human cell lines express multiple populations of Ia-like molecules. Hum Immunol. 1981 Aug; 3(1):67-76.
    View in: PubMed
    Score: 0.015
  37. Expression of cell surface markers after human B lymphocyte activation. Proc Natl Acad Sci U S A. 1981 Jun; 78(6):3848-52.
    View in: PubMed
    Score: 0.015
  38. Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. Blood. 1981 Jun; 57(6):1105-10.
    View in: PubMed
    Score: 0.015
  39. Monoclonal antibody identifies a new Ia-like (p29,34) polymorphic system linked to the HLA-D/DR region. Nature. 1981 Apr 16; 290(5807):591-3.
    View in: PubMed
    Score: 0.015
  40. Antigens on human monocytes identified by monoclonal antibodies. J Immunol. 1981 Apr; 126(4):1435-42.
    View in: PubMed
    Score: 0.015
  41. Surface antigens on malignant Sézary and T-CLL cells correspond to those of mature T cells. Blood. 1981 Mar; 57(3):526-30.
    View in: PubMed
    Score: 0.015
  42. Expression of normal monocyte-macrophage differentiation antigens on HL60 promyelocytes undergoing differentiation induced by leukocyte-conditioned medium or phorbol diester. Leuk Res. 1981; 5(6):491-5.
    View in: PubMed
    Score: 0.015
  43. A unique cell surface antigen identifying lymphoid malignancies of B cell origin. J Clin Invest. 1981 Jan; 67(1):134-40.
    View in: PubMed
    Score: 0.015
  44. Characterization of a human B lymphocyte-specific antigen. J Immunol. 1980 Oct; 125(4):1678-85.
    View in: PubMed
    Score: 0.015
  45. Subset derivation of T-cell acute lymphoblastic leukemia in man. J Clin Invest. 1979 Aug; 64(2):392-7.
    View in: PubMed
    Score: 0.013
  46. T-cell-subset characterization of human T-CLL. Blood. 1979 Jun; 53(6):1066-75.
    View in: PubMed
    Score: 0.013
  47. Mechanism of graft failure in HLA-matched and HLA-mismatched bone marrow transplant recipients. Bone Marrow Transplant. 1989 May; 4(3):239-45.
    View in: PubMed
    Score: 0.007
  48. Use of radiolabeled monoclonal anti-B1 antibody for B lymphocyte imaging in rhesus monkeys. Int J Rad Appl Instrum B. 1987; 14(2):99-105.
    View in: PubMed
    Score: 0.006
  49. Monoclonal antibodies: their use in bone marrow transplantation. Prog Hematol. 1987; 15:137-81.
    View in: PubMed
    Score: 0.006
  50. Purification of common acute lymphoblastic leukemia antigen positive cells from normal human bone marrow. Blood. 1984 Sep; 64(3):662-6.
    View in: PubMed
    Score: 0.005
  51. Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA). J Exp Med. 1983 Jan 01; 157(1):114-29.
    View in: PubMed
    Score: 0.004
  52. Alpha and beta chains of SB and DR antigens are structurally distinct. J Exp Med. 1982 Nov 01; 156(5):1557-62.
    View in: PubMed
    Score: 0.004
  53. Expression of a 26,000-dalton glycoprotein on activated human T cells. Cell Immunol. 1981 Oct; 64(1):192-9.
    View in: PubMed
    Score: 0.004
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.